205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.28%
Revenue growth similar to MPWR's 13.16%. Walter Schloss would see if both companies share industry tailwinds.
13.83%
Gross profit growth similar to MPWR's 13.74%. Walter Schloss would assume both firms track common industry trends.
24.58%
EBIT growth 75-90% of MPWR's 30.14%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
24.89%
Operating income growth at 75-90% of MPWR's 30.14%. Bill Ackman would demand a plan to enhance operating leverage.
18.19%
Net income growth at 50-75% of MPWR's 28.35%. Martin Whitman would question fundamental disadvantages in expenses or demand.
23.46%
EPS growth similar to MPWR's 25.00%. Walter Schloss would assume both have parallel share structures and profit trends.
24.05%
Similar diluted EPS growth to MPWR's 25.93%. Walter Schloss might see standard sector or cyclical influences on both firms.
-0.22%
Share reduction while MPWR is at 0.50%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.10%
Diluted share reduction more than 1.5x MPWR's 0.43%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.22%
Maintaining or increasing dividends while MPWR cut them. John Neff might see a strong edge in shareholder returns.
32.18%
OCF growth under 50% of MPWR's 119.49%. Michael Burry might suspect questionable revenue recognition or rising costs.
39.85%
FCF growth under 50% of MPWR's 1254.20%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
46.99%
10Y revenue/share CAGR under 50% of MPWR's 186.15%. Michael Burry would suspect a lasting competitive disadvantage.
21.16%
5Y revenue/share CAGR under 50% of MPWR's 66.36%. Michael Burry would suspect a significant competitive gap or product weakness.
24.02%
3Y revenue/share CAGR under 50% of MPWR's 52.15%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
407.30%
10Y OCF/share CAGR above 1.5x MPWR's 128.63%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
41.89%
Below 50% of MPWR's 205.95%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
34.40%
3Y OCF/share CAGR under 50% of MPWR's 283.31%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
107.43%
Below 50% of MPWR's 662.48%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
84.05%
5Y net income/share CAGR at 50-75% of MPWR's 117.35%. Martin Whitman might see a shortfall in operational efficiency or brand power.
68.48%
3Y net income/share CAGR 75-90% of MPWR's 81.16%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
28.66%
Below 50% of MPWR's 232.52%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
6.60%
Below 50% of MPWR's 45.35%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1.90%
Below 50% of MPWR's 22.53%. Michael Burry suspects a serious short-term disadvantage in building book value.
1149.23%
Dividend/share CAGR of 1149.23% while MPWR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
194.94%
Dividend/share CAGR of 194.94% while MPWR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
35.78%
3Y dividend/share CAGR of 35.78% while MPWR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
7.34%
AR growth well above MPWR's 6.33%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.62%
Inventory is declining while MPWR stands at 1.11%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.33%
Asset growth at 50-75% of MPWR's 5.59%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.48%
50-75% of MPWR's 4.83%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-0.03%
We’re deleveraging while MPWR stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
3.52%
R&D dropping or stable vs. MPWR's 14.52%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-2.64%
We cut SG&A while MPWR invests at 4.02%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.